Scientific Programmer

As an Oregon Health & Science University (OHSU) Scientific Programmer specializing in genomic, imaging, and clinical analysis applications, you will leverage your talents to change the world and contribute to the elimination of human disease. You are passionate about open-source software and transparent sharing of information. You are enthusiastic about working in a team that finds quantitative insights in complex data and develops interactive tools to enable clinicians and researchers to understand cancer. You have strong experience in thinking analytically and developing software tools. This position will work in a team-oriented software development environment that's committed to transparency and open-source software. The position comes with creative freedom to solve a variety of computational challenges, such as: Supporting genomic analysis in R and Python. Developing web-based data visualizations using libraries such as Angular and React. Developing API-friendly web services in Python or Ruby to manage computational workflows. A successful candidate will contribute to the international development of standardized APIs and data schemas, and develop implementations compatible with such APIs, ensuring that the system is interoperable within the emerging community ecosystem of software tools.

OHSU is ranked as one of the nation's top biomedical institutions in patient care, research, and education, with an annual operating budget of over $2.3 billion, over $340 million in annual grant funding, over 4,000 students and trainees, and nearly 1 million patient visits per year. Multiple departments rank among the top 5 in annual grant funding, including neuroscience, microbiology, ophthalmology, otolaryngology, and emergency medicine. OHSU is one of the nation's fastest growing biomedical institutions, bolstered by long-term resource commitments, such as the $1 billion Phil and Penny Knight "challenge" to support research in OHSU's Knight Cancer Institute, led by Dr. Brian Druker, who pioneered the concept of gene targeted therapy by demonstrating the efficacy of the revolutionary cancer drug Gleevec in chronic myelogenous leukemia. OHSU provides substantial resources to enable data intensive science, including a world-class exascale supercomputing cluster, close interactions and resource commitments by leading technology companies such as Intel, tight integration with clinical and basic research programs across campus, graduate training programs in quantitative biosciences, biostatistics, biomedical informatics, bioinformatics and computational biology, and substantial long-term resource commitments, including the $1 billion Phil and Penny Knight "challenge" to support cancer research, with a significant focus on computation. The Computational Biology Program at Oregon Health and Science University (OHSU), Portland, OR is committed to leading the development of next-generation patient care through discoveries made by big data analytics, enabled by values of open access data, open source code, highly collaborative team science, and professional software engineering methodologies.